Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000409486 | SCV000485769 | likely pathogenic | Salla disease | 2016-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000409486 | SCV004365374 | pathogenic | Salla disease | 2023-12-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr117Leufs*78) in the SLC17A5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC17A5 are known to be pathogenic (PMID: 10581036, 10947946, 15172001). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC17A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 370442). For these reasons, this variant has been classified as Pathogenic. |